Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ZBH Hot Sheet
Join SI Premium – FREE
Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.20, $0.05 better than the analyst estimate of $2.15. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.93 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2024 EPS of $8.00-$8.15, versus the consensus of $7.95.
For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; updates guidance
- Marriott Vacations Worldwide (VAC) Tops Q3 EPS by 7c; offers guidance
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
